$134.50 -0.52 (-0.39%)
2/10/2012 4:02 PM

Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 4 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Featured Broker Partners


Advertisement